Cargando…
Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer
SIMPLE SUMMARY: A substantial fraction of the elderly population suffers from moderate anemia, and blood smear analysis can guide towards a diagnosis of myelodysplastic syndrome (MDS). Nevertheless, in medical laboratories, blood smear review is only performed when quantitative or qualitative flags...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865695/ https://www.ncbi.nlm.nih.gov/pubmed/33494332 http://dx.doi.org/10.3390/cancers13030389 |
_version_ | 1783647906926952448 |
---|---|
author | Ravalet, Noémie Foucault, Amélie Picou, Frédéric Gombert, Martin Renoult, Emmanuel Lejeune, Julien Vallet, Nicolas Lachot, Sébastien Rault, Emmanuelle Gyan, Emmanuel Bene, Marie C. Herault, Olivier |
author_facet | Ravalet, Noémie Foucault, Amélie Picou, Frédéric Gombert, Martin Renoult, Emmanuel Lejeune, Julien Vallet, Nicolas Lachot, Sébastien Rault, Emmanuelle Gyan, Emmanuel Bene, Marie C. Herault, Olivier |
author_sort | Ravalet, Noémie |
collection | PubMed |
description | SIMPLE SUMMARY: A substantial fraction of the elderly population suffers from moderate anemia, and blood smear analysis can guide towards a diagnosis of myelodysplastic syndrome (MDS). Nevertheless, in medical laboratories, blood smear review is only performed when quantitative or qualitative flags occur upon complete blood count (CBC). Consequently, the suspicion of MDS can be delayed in the absence of systematic blood smear observation, which is crucial to initiate a full diagnosis process by cytological analysis of bone marrow aspiration. The Beckman Coulter DxH 800 hematology analyzer (Beckman-Coulter, Brea, CA) is widely used over the world. We propose in this study the clinical use of 10 unexploited “research parameters” for early detection of subclinical MDS by selective triggering of blood smear examination. ABSTRACT: The incidence of myelodysplastic syndrome increases with aging and the early diagnosis enables optimal care of these diseases. The DxH 800 hematology analyzer measures and calculates 126 cytological parameters, but only 23 are used for routine CBC assessment. The goal of this study was to use the 103 unexploited “research parameters” to develop an algorithm allowing for an early detection of subclinical MDS patients by triggering morphological analysis. Blood sample parameters from 101 MDS patients and 88 healthy volunteers were analyzed to identify the critical “research parameters” with: (i) the most significant differences between MDS patients and healthy volunteers, (ii) the best contributions to principal component analysis (PCA), first axis, and (iii) the best correlations with PCA, first two axes (cos(2) > 0.6). Ten critical “research parameters” of white blood cells were identified, allowing for the calculation of an MDS-likelihood score (MDS-LS), based on logistic regression. Automatic calculation of the MDS-LS is easily implementable on the middleware system of the DxH 800 to generate a flag for blood smear review, and possibly early detection of MDS patients in the general population. |
format | Online Article Text |
id | pubmed-7865695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78656952021-02-07 Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer Ravalet, Noémie Foucault, Amélie Picou, Frédéric Gombert, Martin Renoult, Emmanuel Lejeune, Julien Vallet, Nicolas Lachot, Sébastien Rault, Emmanuelle Gyan, Emmanuel Bene, Marie C. Herault, Olivier Cancers (Basel) Article SIMPLE SUMMARY: A substantial fraction of the elderly population suffers from moderate anemia, and blood smear analysis can guide towards a diagnosis of myelodysplastic syndrome (MDS). Nevertheless, in medical laboratories, blood smear review is only performed when quantitative or qualitative flags occur upon complete blood count (CBC). Consequently, the suspicion of MDS can be delayed in the absence of systematic blood smear observation, which is crucial to initiate a full diagnosis process by cytological analysis of bone marrow aspiration. The Beckman Coulter DxH 800 hematology analyzer (Beckman-Coulter, Brea, CA) is widely used over the world. We propose in this study the clinical use of 10 unexploited “research parameters” for early detection of subclinical MDS by selective triggering of blood smear examination. ABSTRACT: The incidence of myelodysplastic syndrome increases with aging and the early diagnosis enables optimal care of these diseases. The DxH 800 hematology analyzer measures and calculates 126 cytological parameters, but only 23 are used for routine CBC assessment. The goal of this study was to use the 103 unexploited “research parameters” to develop an algorithm allowing for an early detection of subclinical MDS patients by triggering morphological analysis. Blood sample parameters from 101 MDS patients and 88 healthy volunteers were analyzed to identify the critical “research parameters” with: (i) the most significant differences between MDS patients and healthy volunteers, (ii) the best contributions to principal component analysis (PCA), first axis, and (iii) the best correlations with PCA, first two axes (cos(2) > 0.6). Ten critical “research parameters” of white blood cells were identified, allowing for the calculation of an MDS-likelihood score (MDS-LS), based on logistic regression. Automatic calculation of the MDS-LS is easily implementable on the middleware system of the DxH 800 to generate a flag for blood smear review, and possibly early detection of MDS patients in the general population. MDPI 2021-01-21 /pmc/articles/PMC7865695/ /pubmed/33494332 http://dx.doi.org/10.3390/cancers13030389 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ravalet, Noémie Foucault, Amélie Picou, Frédéric Gombert, Martin Renoult, Emmanuel Lejeune, Julien Vallet, Nicolas Lachot, Sébastien Rault, Emmanuelle Gyan, Emmanuel Bene, Marie C. Herault, Olivier Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer |
title | Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer |
title_full | Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer |
title_fullStr | Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer |
title_full_unstemmed | Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer |
title_short | Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer |
title_sort | automated early detection of myelodysplastic syndrome within the general population using the research parameters of beckman–coulter dxh 800 hematology analyzer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865695/ https://www.ncbi.nlm.nih.gov/pubmed/33494332 http://dx.doi.org/10.3390/cancers13030389 |
work_keys_str_mv | AT ravaletnoemie automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer AT foucaultamelie automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer AT picoufrederic automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer AT gombertmartin automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer AT renoultemmanuel automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer AT lejeunejulien automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer AT valletnicolas automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer AT lachotsebastien automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer AT raultemmanuelle automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer AT gyanemmanuel automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer AT benemariec automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer AT heraultolivier automatedearlydetectionofmyelodysplasticsyndromewithinthegeneralpopulationusingtheresearchparametersofbeckmancoulterdxh800hematologyanalyzer |